Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

Bifidobacterium longum (B. longum) ES1 is a probiotic strain capable of modulating microbiome composition, anti-inflammatory activity and intestinal barrier function. We investigated the use of B. Longum ES1 in the treatment of patients with diarrhoea-predominant irritable bowel syndrome (IBS-D). Si...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Caviglia, Gian Paolo, Tucci, Alessandra, Pellicano, Rinaldo, Fagoonee, Sharmila, Rosso, Chiara, Abate, Maria Lorena, Olivero, Antonella, Armandi, Angelo, Vanni, Ester, Saracco, Giorgio Maria, Bugianesi, Elisabetta, Astegiano, Marco, Ribaldone, Davide Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464152/
https://ncbi.nlm.nih.gov/pubmed/32717980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082353
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars